Online Comments to the Pharmaceutical Benefits Advisory Committee (PBAC)

You are welcome to provide comments from a personal or group perspective for consideration by the PBAC when the submission is considered.

Page last updated: 25 July 2023

IMPORTANT: The PBAC operates to a fixed timetable and information received late cannot be considered.

Consultation is open for the November 2023 PBAC agenda

Providing consultation input

To complete the consumer input form, please go to the Office of Health Technology Assessment (OHTA) Consultation Hub and click on the PBAC link. Please note we do not accept petitions, duplicate submissions from the same author, form letters (multiple copies of the same statements of support for access) or any material that is inappropriate in language or tone.

When you have completed the form and pressed the SUBMIT button, your form will be sent electronically to the PBAC Secretariat and you will receive an email confirmation of receipt which will include a copy of your comments.

If you have problems submitting this form please contact